Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer

Technology appraisal guidance
Reference number: TA192
Published: 28 July 2010

Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination

Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination

Lung cancer (non-small-cell, first line) - gefitinib: final appraisal determination
27 May 2010
(199.05 Kb 57 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 25 May 2010